期刊文献+

心理干预在慢性白血病患者焦虑抑郁情绪干预的效果 被引量:4

Efficacy of Psychological Intervention on Anxiety and Depression of Chronic Leukemia Patients
下载PDF
导出
摘要 目的探讨心理干预在慢性白血病患者焦虑抑郁情绪干预的效果。方法将清远市人民医院收治的86例慢性白血病患者随机分为观察组与对照组,每组各43例,对照组患者进行常规护理,观察组在对照组基础上进行心理护理干预,包含认知心理干预、个体化心理干预及社会支持性心理干预,比较两组患者干预前后的焦虑(SAS)及抑郁(SDS)评分及分级。结果观察组干预6个月后的SAS评分及SDS评分均显著高于对照组(P<0.001);观察组干预6个月后的焦虑及抑郁状况分级显著优于对照组(P<0.05);观察组干预6个月后的焦虑及抑郁状况分级显著优于干预前(P<0.05)。结论心理干预可有效缓解慢性白血病患者的焦虑及抑郁情绪,降低抑郁及焦虑分级状况。 Objective To explore the efficacy of psychological intervention on anxiety and depression of chronic leukemia patients. Methods 86 cases of chronic leukemia patients from Qingyuan City People's Hospita Hospital were randomly divided into the observation group and the control group. each group contained 43 patients. The control group were used the routine care,and the observation group were used the psychological care on the basis of the control group. that included cognitive psychological intervention,individual psychological and social support intervention psychological intervention. the anxiety( SAS) and depression( SDS) score and grade were compared before and after the intervention. Results The SAS and SDS score in the observation group were significantly lower than the control group,P〈0. 05; the anxiety and depression Status classification in the observation group were significantly better than the control group( P〈0. 05). the anxiety and depression status classification in the observation group after the 6th month intervention were significantly better than before the intervention( P〈0. 05). Conclusion Psychological intervention can relieve nxiety and depression of chronic leukemia,and reduce depression and anxiety grade status.
作者 刘佳璋
出处 《哈尔滨医药》 2016年第1期89-91,共3页 Harbin Medical Journal
基金 规范化序贯肠内营养支持联合胆汁回输在肝内胆咎结石术后者应用的护理研究(2014B046)
关键词 心理干预 慢性白血病 焦虑 抑郁 Psychological intervention Chronic leukemia Anxiety Depression
  • 相关文献

参考文献6

二级参考文献41

  • 1余志华,刘丛.恶性血液病患者焦虑抑郁对免疫功能的影响及护理干预[J].中国实用护理杂志,2005,21(5):2-4. 被引量:36
  • 2王海哲,孔莉.肿瘤化疗不良反应与对策[M].济南:山东科学技术出版社,2002.4
  • 3Orazi A, Bennett J, Germing U, et al. Chronic myelomonocytic leukaemia//WI-IO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon:IARC Press, 2008: 15-28.
  • 4Kern W, Baeher U, Haferlaeh C, ctal. Acute monoblastie/monoeytie leukemia and chronic myelomonoeytic leukemia share common immunophenotypie features but differ in the extent of aberrantly expressed antigens and amount of granulytie cells. Leuk Lymphoma, 2011, 52: 92-100.
  • 5Breccia M, Latagliata R, Mengarelli A, et al. Prognostic factors in myelodysplastic and myeloproliferative types of chronic myelomonocytic leukaemia: a retrospective analysis of 83 patients from a single institution. Haematologica, 2004, 89: 866-868.
  • 6Onida F, Kantarjian HM, Smith TL, et al. Prognostic factors and scoring systems in chronic myelomonocytic leukaemia: a retrospective analysis of 213 patients. Blood, 2002, 99: 840-849.
  • 7Germing U, Strupp C, Aivado M, et al. New prognostic parameters for chronic myelomonocytic leukaemia. Blood, 2002, 100:731-732.
  • 8Such E, Cervera J, Costa D, et al. Cytogenetic risk stratification in chronic myelomonocytic leukemia. Haematologica, 2011, 96: 375-383.
  • 9Mathew RA, Bennett JM, Liu JJ, et al. Cutaneous manifestations in CMML: Indieation of disease acceleration or transformation to AML and review of the literature. Leuk Res, 2012,36: 72-80.
  • 10Ricci C, Fermo E, Corti S, et al. RAS mutations contribute to evolution of chronic myelomonocytic leukaemia to the proliferative variant. Clin Cancer Res, 2010, 16: 2246-2256.

共引文献92

同被引文献68

引证文献4

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部